API Docs
All documentation Fundamental API Live (Delayed) API EOD Historical API Intraday API Real-Time (Websockets) API Financial News API Delisted Data API
Solutions
New & Popular APIs
Show all APIs Fundamental Data APIs Historical End-of-Day API Real-time Prices API Financial Events & News API Indices Historical Constituents API 40 000 Stock Market Logos API Forex Data APIs
Other products
Google Sheets Add-on Excel Add-on Coding Libraries (Python, R, etc) Wordpress Add-on
API Marketplace
Community
Academy 152 articles Forum Github 14 repos
Pricing
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. KO /
  3. 288330.KO

Bridge Biotherapeutics Inc. (288330 KO) stock market data APIs

₩3135 -230(-6.8%) as of November 25, 2024
Price chart is built with Anychart

Bridge Biotherapeutics Inc. Financial Data Overview

3365
3135
-
3535
3115
1451.3001-6100
0
0
0
-194.4545
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: '288330',
Type: 'Common Stock',
Name: 'Bridge Biotherapeutics Inc.',
Exchange: 'KO',
CurrencyCode: 'KRW',
CurrencyName: 'Korean Won',
CurrencySymbol: '₩',
CountryName: 'Korea',
CountryISO: 'KR',
OpenFigi: NULL,
ISIN: NULL,
CIK: NULL,
EmployerIdNumber: NULL,
FiscalYearEnd: NULL,
IPODate: NULL,
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
}

Bridge Biotherapeutics Inc. Fundamental Data is available in our Financial Data APIs

  • Net Revenue 0
  • EBITDA 0
  • Earnings Per Share
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $59.99 See full price
Get sample
of Fundamental API Data

Get Bridge Biotherapeutics Inc. Earnings via APIs

  • Latest Release 2024-06-30
  • EPS/Forecast NaN

Get Bridge Biotherapeutics Inc. End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get Bridge Biotherapeutics Inc. latest news via APIs

Bridge Biotherapeutics to Present Updated Preclinical Data of BBT-207 at the AACR 2023 Annual Meeting

The abstract of BBT-207 preclinical studies is now available on the AACR website Preclinical data suggests that BBT-207 may have the potential to be used as a broad-spectrum fourth generation EGFR TKI...
  • AACR
  • BIOTECH COMPANY
  • BIOTHERAPEUTICS
  • BRIDGE
  • LUNG CANCER
  • MUTATIONS
  • NSCLC
  • POSTER PRESENTATION
  • PRECLINICAL DEVELOPMENT

Bridge Biotherapeutics Presents Phase 2a Clinical Trial Results For BBT-401, a Drug Candidate to Treat Ulcerative Colitis

BBT-401 meets safety endpoints achieved in previous clinical studies The drug candidate did not achieve an improved clinical response compared to the placebo study group 54.5% of the treatment cohort ...
  • BIOTHERAPEUTICS
  • BRIDGE
  • CLINICAL RESPONSE RATE
  • CLINICAL STUDIES
  • COHORT STUDY
  • PHASE 2A
  • SAFETY PROFILE
  • TREATMENT GROUP
  • ULCERATIVE COLITIS
News API is available at any package from $19.99 See full price
Get sample of News API
Do you have any questions?
support@eodhistoricaldata.com